PF-4995274

N/A

Report date: 2022/07/26 20:00:33
NME

Base Information

Drug NamePF-4995274
Drug Alias NameTBPTPF-4995274PF-04995274
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor agonists
TargetsSerotonin 4 (5-HT4) receptor
Therapy Area/IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncUniversity Of Oxford
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A